OncoGenomX Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Series A
  • (Upcoming)

  • Latest Deal Amount
  • $10M

  • Investors
  • 4

OncoGenomX General Information

Description

Developer of an artificial intelligence-decision learning prediction software support service designed to eliminate uncertainty in cancer treatment by providing precise drug-tumor matching solutions. The company's software is grounded in human data and trained to understand the genetic and biological ramifications of treatment efficacy and treatment resistance of individual breast cancers and the gene suite, enabling healthcare professionals to have permanent disease control and better life expectancy for patients.

Contact Information

Website
www.oncogenomx.ch
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Gewerbestrasse 24
  • Innovation Center, University Basel
  • 4123 Allschwil
  • Switzerland
+41 079
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Digital Health, Artificial Intelligence & Machine Learning, HealthTech, Life Sciences, Oncology
Corporate Office
  • Gewerbestrasse 24
  • Innovation Center, University Basel
  • 4123 Allschwil
  • Switzerland
+41 079

OncoGenomX Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OncoGenomX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series A) $10M Upcoming Product In Beta Test
5. Later Stage VC 31-Dec-2024 Completed Product In Beta Test
4. Accelerator/Incubator Completed Product In Beta Test
3. Accelerator/Incubator 01-Dec-2023 Completed Startup
2. Accelerator/Incubator 31-Mar-2022 Completed Startup
1. Grant 04-Aug-2020 $10.7K Completed Pre-Clinical Trials
To view OncoGenomX’s complete valuation and funding history, request access »

OncoGenomX Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an artificial intelligence-decision learning prediction software support service designed to eliminate unce
Diagnostic Equipment
Allschwil, Switzerland
8 As of 2025

Salt Lake City, UT
 

Irvine, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OncoGenomX Competitors (4)

One of OncoGenomX’s 4 competitors is Myriad Genetics, a Corporation company based in Salt Lake City, UT.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Myriad Genetics Corporation Salt Lake City, UT
Agendia Venture Capital-Backed Irvine, CA
Veracyte Formerly VC-backed South San Francisco, CA
Exact Sciences Formerly VC-backed Madison, WI
To view OncoGenomX’s complete competitors history, request access »

OncoGenomX Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

OncoGenomX Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4739801-A1 Classification, treatment, and treatment response of cancer patients Pending 06-Jul-2023
WO-2025008394-A1 Classification, treatment, and treatment response of cancer patients Inactive 06-Jul-2023

OncoGenomX Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OncoGenomX Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Gold Track Accelerator/Incubator
Tech4Eva Accelerator/Incubator
Venture Kick Accelerator/Incubator
28DIGITAL Accelerator/Incubator
To view OncoGenomX’s complete investors history, request access »

Ready to get started?

Request a free trial

OncoGenomX FAQs

  • When was OncoGenomX founded?

    OncoGenomX was founded in 2019.

  • Where is OncoGenomX headquartered?

    OncoGenomX is headquartered in Allschwil, Switzerland.

  • What is the size of OncoGenomX?

    OncoGenomX has 8 total employees.

  • What industry is OncoGenomX in?

    OncoGenomX’s primary industry is Diagnostic Equipment.

  • Is OncoGenomX a private or public company?

    OncoGenomX is a Private company.

  • What is OncoGenomX’s current revenue?

    The current revenue for OncoGenomX is .

  • How much funding has OncoGenomX raised over time?

    OncoGenomX has raised $1M.

  • Who are OncoGenomX’s investors?

    Gold Track, Tech4Eva, Venture Kick, and 28DIGITAL have invested in OncoGenomX.

  • Who are OncoGenomX’s competitors?

    Myriad Genetics, Agendia, Veracyte, and Exact Sciences are competitors of OncoGenomX.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process